Topic: non-invasive screening methods

Craif Secures $22M to Advance Early Cancer Detection Tech

Craif, a Japanese biotech startup, secured $22 million in Series C funding to expand its urine-based cancer detection technology into the U.S. market, addressing the limitations of current invasive screening methods. The company’s miSignal platform, utilizing microRNA biomarkers in urine, has alr...